The WannaCry ransomware attack that successfully targeted Merck is not the only cyberattack to which the pharmaceutical industry has fallen victim. As pharmaceutical and biotechnology companies move toward greater digitalization and the storage of more valuable data, their digital security practices become more and more critical.
With the barrage of information coming into a system, separating the noise from the genuine threats can be a difficult process. This is where AI can come in, to help you separate the real risks to your business from normal network noise.
A study by Ponemon Institute and sponsored by IBM Resilient has found that 77 percent of respondents admit they do not have a formal cyber security incident response plan (CSIRP) applied consistently across their organization.
